Earnings Per Share

9 Months Ended

Sep. 30, 2023

Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(4.9)	$	(25.0)	$	(10.9)	$	(31.2)

Denominator:
Weighted average shares outstanding- basic	125,747		88,907		125,559		88,604
Weighted average shares outstanding- diluted (1)	125,747		88,907		125,559		88,604

Loss per share:
Basic	$	(0.04)	$	(0.28)	$	(0.09)	$	(0.35)
Diluted (1)	$	(0.04)	$	(0.28)	$	(0.09)	$	(0.35)

Dilutive securities outstanding not included in the computation of income (loss) per share as their effect is antidilutive:
Stock options	1,421		1,323		1,412		1,527
Restricted shares	208		604		202		669

(1)The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.